Regenerative Medical Technology (RMTG) Cash from Financing Activities (2018 - 2026)
Regenerative Medical Technology (RMTG) posted quarterly Cash from Financing Activities of $318000.0 for Q1 2026, up 206.0% quarter-over-quarter from -$300000.0 in Q4 2023.
Regenerative Medical Technology (RMTG) Cash from Financing Activities (2018 - 2026) Analysis & Trends
Regenerative Medical Technology's Cash from Financing Activities history runs 7 years deep, the most recent figure standing at $318000.0 for Q1 2026.
- In Q1 2026, Cash from Financing Activities changed N/A year-over-year to $318000.0; the TTM figure through Mar 2026 stood at $18000.0 (changed N/A YoY), while the FY2025 annual figure was $1.1 million, changed N/A from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $318000.0, up from -$300000.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $318000.0 in Q1 2026, with the low at -$300000.0 in Q4 2023.
- The 3-year median for Cash from Financing Activities is -$6494.0 (2022), against an average of -$1803.7.
- The sharpest annual moves came in 2022 and 2023: Cash from Financing Activities jumped 99.42% in 2022, then slumped 4519.65% in 2023.
- Regenerative Medical Technology's Cash from Financing Activities stood at -$6494.0 in 2022, then plunged by 4519.65% to -$300000.0 in 2023, then jumped by 206.0% to $318000.0 in 2026.
- Business Quant data shows RMTG's Cash from Financing Activities at $318000.0 in Q1 2026, -$300000.0 in Q4 2023, and -$9850.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -426.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -1.22 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 14.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -6.05 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 36.24 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -16.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 27.18 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -273.15 Mn |
| 10 | Regenerative Medical Technology | 1.58 Mn | 515,228.12 | 1.77 Mn | 318,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 318,000.00 |
| Mar 31, 2026 | 318,000.00 |
| Dec 31, 2023 | -300,000.00 |
| Dec 31, 2023 | -300,000.00 |
| Mar 31, 2023 | -9,850.00 |
| Mar 31, 2023 | -9,850.00 |
| Dec 31, 2022 | -6,494.00 |
| Dec 31, 2022 | -6,494.00 |
| Sep 30, 2022 | -1,459.00 |
| Sep 30, 2022 | -1,459.00 |
| Jun 30, 2022 | -11,427.00 |
| Jun 30, 2022 | -11,427.00 |
| Mar 31, 2022 | -1,396.00 |
| Mar 31, 2022 | -1,396.00 |
| Dec 31, 2021 | 998,642.00 |
| Dec 31, 2021 | 998,642.00 |
| Sep 30, 2021 | -250,454.00 |
| Sep 30, 2021 | -250,454.00 |
| Jun 30, 2021 | 10.50 Mn |
| Jun 30, 2021 | 10.50 Mn |